Peak Bio, Inc. — key financial figures for fiscal year 2023 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:

Revenue (FY2023)

$367.9K

Net Income/Loss (FY2023)

-$12.8M

Total Assets (FY2023)

$2.6M

Total Equity (FY2023)

-$18.2M

Cash Flows from Operating Activities (FY2023)

-$4.8M

Source: Peak Bio, Inc. 10-K filing (FY2023). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.